Advertising & Promotion Hot Topics in Today’s FDA and FTC Landscape
Do’s, Don’ts and Real-World Examples

Thursday, June 7, 2018 · 1:30 p.m. - 3:00 p.m. EDT

Drug and device advertising, marketing and promotion has come a long way from 30-second TV spots. These days the cutting edge is social media, product placement, engaging influencers, reality TV, pop-up shops and more.

Things you ought to be aware of. Things you may want to do yourself. Things that could get you in trouble with the FDA, FTC and other agencies if you make missteps.

Having trouble keeping up? So are your competitors. So are the regulators themselves. But not Washington lawyers Gillian M. Russell Esq. and Heather Bañuelos Esq. of King & Spalding’s FDA and Life Sciences practice.

Mark your calendar for Thursday, June 7, when Ms. Russell and Ms. Bañuelos share the virtual stage of an FDAnews webinar that aims to bring you up to speed on regulatory trends present and future at the FDA, FTC and elsewhere. You’ll discover:

  • Significant updates to FDA enforcement of pharmaceutical and medical device promotion, including key focus areas and emerging trends
  • Practical lessons from FDA’s renewed focus on direct-to-consumer TV ads, including how elements such as music selection, pacing and distracting visuals can result in an enforcement letter
  • Risk disclosure: Getting this FDA priority area right in product promotion, especially when launching a social media campaign
  • Insightful predictions on future FDA hot topics based on ongoing First Amendment initiatives and newly announced research by the Office of Prescription Drug Promotion
  • Valuable advice on the nuanced implications of FTC’s increasing focus on transparency as it bears on novel promotional strategies such as use of influencers, spokespersons, patient bloggers and native advertising
  • Real world examples of unique promotional strategies along with key legal, regulatory, and compliance considerations
  • And much more!

Of course you need to advertise, market and promote your products. Of course you ought to explore promising, unconventional methods that promise fat purses in a fast-changing era. Just make sure to take all appropriate precautions. That means knowing the state of regulation at the FDA, FTC and elsewhere, now and down the road. Register now.

BONUS: Order the webinar plus audio recording/transcript or the 24/7 encore plus audio recording/transcript for $487, and receive a FREE copy of Advertising Drugs and Devices: Keys to FDA and FTC Compliance (retail value $177).

Advertising Drugs and Devices: Keys to FDA and FTC Compliance
Could your next advertising campaign land you in hot water with the FDA or FTC? Possibly open your company up to liability suits? Thisa hands-on guide, lays out the advertising landscape as the government sees it — regulations, requirements, expectations — and shows  you the right road to take to compliance.


Who Will Benefit

From drugs and biologics to devices and diagnostics, nearly every organization with FDA-regulated products will benefit from this informative and practical workshop. Specific job titles include:

  • Executive suite
  • Regulatory
  • Compliance
  • Legal counsel
  • Strategic planning
  • Marketing/sales
  • Corporate communications/public affairs

Webinar plus Audio Recording/Transcript with BONUS
Learn more

$487

add to cart

Webinar only
Learn more

$287

add to cart

24/7 Encore plus Audio Recording/Transcript with BONUS
Learn more

$487

add to cart

24/7 Encore Presentation
Learn more

$287

add to cart

Audio Recording/Transcript
Learn more

$287

add to cart

 

 

 

Meet Your Presenters

Gillian M. Russell Esq.

Counsel
King & Spalding

Gillian Russell, Esq. is counsel in King & Spalding’s FDA & Life Science Practice Group. Gillian has significant experience advising clients on a variety of advertising and promotion activities in connection with new product launches, physician and DTC advertising, investor communications, and social media. Gillian has served as primary legal counsel on the Promotional Review Committees (PRC) of a number of pharmaceutical and medical device manufacturers.

Heather Bañuelos Esq.

Counsel
King & Spalding

Heather Bañuelos, Esq. is counsel in King & Spalding’s FDA & Life Science Practice Group, advising clients on a wide range of regulatory, compliance and enforcement issues for drugs, devices, foods, and cosmetics, with a special focus on the promotion and advertising of FDA-regulated products. She regularly acts as primary legal counsel on pharmaceutical companies’ Promotional Review Committees (PRC) and Scientific Review Committees (SRC), advising on promotional and non-promotional communications and activities.

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.

Phone (703) 538-7600 | Fax (703) 538-7676 | Toll free (888) 838-5578 | Email customerservice@fdanews.com

© 2018 FDAnews